1/86
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
THE COURSE OF DRUG ACTION FROM DOSE TO EFFECT COMPRISES 3 STAGES
DRUG ADMINISTRATION
PHARMCOKINETIC PHASE
PHARMCODYNAMIC PHASE
THE DRUG ADMINSTRATION PHASE - IS THE METHOD
MADE AVAILABLE TO THE BODY
DRUGS DIRECTLY TO THE RESP TRACT USE THE INHALATION INHALATION METHOD
LIQIUD SOLUTION
SUSPENSION
DRY POWDER
MOST COMMON DEVIOSES TO ADMINSTER INHALED AERSOLS ARE
MDI
SOFT MIST INHALER (SMI - RESPIMAT)
SVN
DRY POWDER (DPI)
ADVANTAGES OF INHALED AERSOLS
AEROLS DOSES ARE USUALLY SMALLER DOSES FOR SYSTEMIC ADMIN
ONSET OF DRUG IS RAPID
DELIVERY IS TARGETED TO THE ORGAN REQUIRING TREATMENT
SYSTEMIC SIDE EFFECTS ARE OFTEN FEWER AND LESS SEVERE
DISADVANTAGES OF INHALED AERSOLS
THE LACK OF VARIABLE AFFACTING THE DELIVERED DOSE
LACK OF ADEQUETE KNOWLEDGE OF DEVICE PERFORMANCE
USE AMONG PT AND CAREGIVER
PHARMCOKINETIC PHASE DESCRIBES
TIME COURSE AND DISPOSITION OF DRUG IN BOIDY BASED ON ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION.
DOES FULLY IONIZED AERSOL DRUG HAVE ANY SYSTEMIC SIDE EFFCTS
LITTLE IR NONE
NON IONIZED AERSOLS DRUGS ARE
LIPID SOLUBLE
NON AERSOLIZED DRUGS DIFFUSE ACROSS
THE CELL MEMBRANE INTO BLOOD STREAM PRODUCING SYSTEMIC SIDE EFFECTS
L/T RATIO MEANS
LUNG AVAILABILITY/TOTAL SYSTEMIC AVAILABILITY RATIO QUANTIFIES EFFICIENCY OF A DELIVERY TO THE LUNG
PHARMACODYNAMIC PHASE
MECHANISM BY WHICH DRUG ACTION PRODUCES ITS EFFECTS ON THE BODY
DRUG EFFECTS ARE CAUSED BY A COMBINATION
A DRUG MITH AMATCHING RECEPTOR
DRUG SIGNALING MECHANISM INCLUDE
MEDIATION BY G PROTIEN (GUANINE NUCLEOTIDE) LINKED RECEPTOR
ATTACHEMENTS TO INTRACELLULAR RECEPTORS BY LIPD SOLUBLE DRUGS
WHAT IS ANEXAMPLE OF A LIPD SOLUBLE DRUG
CORTICOSTEROIDS
WHAT ARE EXAMPLES OF MEDIATION BY G PROTIEN LINKED RECEPTORS
BETA adrenergic receptors, muscarinic
WHAT TYPE OF RECEPTORS WORK ON THE SYMPATHETIC SYSTEM
ADRENERGIC
WHAT RECEPTORS WORK ON THE PARASYMPATHTEIC
CHOLINERGIC
WHAT IS THE NEUROTRANSMITTER OF PARASYMPATHETIC SYSTEM
ACETYLCHOLINE
WHAT IS TEH NEURTRANSMITTER OF THE SYMPATHETIC SYSTEM
NOREPINEPHRINE
WHAT IS AN AGONIST DRUG
STIMULATING AGENT
WHAT IS AN ANAGONIST
BLOCKING AGENT
WHAT IS AN ADRENGIC DRUG
DRUG THAT STIMULATES A RECEPTOR TO RESPOND TO NOREPHINEPHRINE OR EPINEPHRINE
WHAT IS AN ANTIADRENERGIC DRUG
DRUG THAT BLOCKS THE RECEPTOR FOR NOREPINEPHRINE OR EPINEPHRINE
WHAT IS A CHOLINERGIC DRUG
A DRUG THAT STIMULATES A RECEPTOR FOR ACETYLCHOLINE OR ACTS LIKE ACETYLCHOLINE
WHAT IS AN ANTICHOLINERGIC DRUG
A DRUG THAT BLOCKS A RECEPTOR FOR ACETYLCHOLINE OR ACTS AGAINST ITS ACTIONS
WHAT IS A MUSCARINIC DRUG
A DRUG THAT STIMULATES ACTEYLCHOLINE RECEPTORS SPECIFICALLY AT PARASYMPATHETIC NERVE ENDING SITES
INDICATION FOR USE - ADRENERGIC DRUGS
SHORT ACTING
LONG ACTING
RACEMIC EFFECTS
WHAT DOES A SHORT ACTING ADRENEGIC DRUG DO
FOR RELEIF OF ACUTE REVERSIBLE AIRFLOW OBSTRUCTION
RESCUE AGENTS
WHAT DOES A LONG ACTING ADRENERGIC DRUG DO
FOR MAINTENANCE
FOR MAINTENANCE FOR BRONCHODILATION IN PT WITH OBSTRUCTIVE LUNG DISEASE
WHAT DOES RACEMIC EPI DO
HELPS TO REDUCE AIRWAY SWELLING AFTER EXTUBATION OR DURING CROUP OR EPIGLOTTIS
TO CONTROL AIRWAY BLEEDING DURING ENDOSCOPY
MODE OF ACTION AND EFFECTS OF ADRENERGIC DRUGS
ALPHA RECEPTOR - CAUSES VASOCONSTRICTION AND VASOPRESSOR EFFECT
BETA 1 RECEPTOR - CAUSES INCREASED HEART ARTE AND HEART CONTTRACTATILITY
BETA 2 RECEPTOR - CAUSES RELAXATION OF BRONCHIAL SMOOTH MUSCLE
STIMULATES MUCOCILIARY ACTIVITY AND HAS SOME INHIBITORY ACTION ON INFLAMMATION MEDIATOR RELAESE
3 SUB GROUPS OF ADRENERGIC BRONCHODILATORS
ULTRA SHORT ACTING
SHORT ACTING
LONG ACTING
ULTRA SHORT ACTING EXAMPLES OF ADRENERGIC BRONCHODILATORS ARE
RACEMIC EPI
WHAT DOES THE ULTRA SHORT ACTING ADRENERGIC BROCHODILATOR DO
IT IS METABOLIZED BY COMT
WHAT ARE EXAMPLES OF SHORT ACTING NON-CATECHOLEMINE ADRENERGIC BRONCHODILATORS
ALBUTEROL
LEVALBUTEROL
METAPROTEROL
HOW DOES THE SHORT ACTING NON-CATECHOLIME ADRENERGIC BRONCHODILATOR WORK
USED FOR MAINTENANCE
DURATION OF ACTION IS ABOUT 6 HOURS
WHAT ARE EXAMPLES OF LONG ACTING ADRENERGIC BRONCHODILATORS
SALMETEROL
FORMOTEROL
ARFORMOTEROL
HOW DOES THE LONG ACTING ADRENERGIC BRONCHODILATOR WORK
DURATION OF ACTION IS 12 HOURS WITH THE EXCEPTION OF INDACATEROL, WHICH LASTS 24 HOURS.
MOST COMMON SIDE EFFCTS OF ADRENERGIC BRONCHODILATOR
TREMOR
HEADACHE
INSOMNIA
NERVOUSNESS
ASSESSMENT OF BRONCHODILATOR THERAPY (ADRENEGIC)
BASED ON INDICATIONS FOR AERSOL AGENT
VITALS SIGNS
BREATH SOUNDS
BREATHING PATTERN
PT SUBJECTIVE RESPONSE IS IMPORTANT TO EVALUATE
INIDCATION FOR USE FOR ADRENERGIC BRONCHODILATORS
MAINTENANCE TX IN COPD
COMBINED WITH BETA AGONIST INDICATED FOR USE WITH PT WITH COPD WHO ARE RECIEVING REGULAR TX AND REQUIRE ADDITIONAL BRONCHODILATION FOR RELIEF OF AIRFLOW OBSTRUCTION
WHAT IS THE IEXAMPLES OF ANTICHOLINERGIC BROCHODILATOR
IPATROPIUM BROMIDE
ACIDIUM BROMIDE
TIOTROPIUM BROMIDE
UMCLIDIUM BROMIDE
WHAT ARE EXAMPLES OF A COMBINED ANTICHOLINERGIC AND BETA AGONIST
IPATROPIUM BROMIDE AND ALBUTEROL (DUONEB)
UMECLIDIUM BROMIDE AND VILANTEROL (ANORO ELIPTA)
MODE OF ACTION FOR ANTICHOLINERGERIC BRONCHODILATOR
AGENTS ACT AS COMPETIVE ANTAGONISTS AT FOR ACTEYLCHOLINE ON AIRWAY SMOOTH MUSCLE
ADVERSE EFFECTS OF ANTICHOLINERGIC BRONCHODILATOR
DRY MOUTH
PUPILLARY DILATION
LENS PARALYSIS
INCREASED INTRAOCCULAR PRESSURE
INCREASED HEART RATE
URINARY RETENTION
ALTERED MENTAL STATE
SIDE EFFECTS SEEN WITH ANTICHOLINERGIC AEROSOL AGENTS -
SVN
MDI
DPI
DRY MOUTH
COUGH
SIDE EFFECTS SEEN WITH ANTICHOLINERGIC AEROSOL AGENTS -
MDI
NERVOUSNESS
IRRITAION
DIZZINESS
HEADACHE
PALPATION
RASH
SIDE EFFECTS SEEN WITH ANTICHOLINERGIC AEROSOL AGENTS -
SVN
DPI
PHARYNGITIS
FLU LIKE SYMPTOMS
BRONCHITIS
UPPER RESP INFECTION
NAUSEA
OCCASIONAL BRONCHOCONSTRICTION
EYE PAIN
URINARY RETENTION
MUCUS CONTROLLING AGENTS HOW ARE THE TYPICALLY GIVEN
AEROSL OR DIRECT TRACHEAL INSTILLATION
WHY ARE MUCUS CONTROLLING AGNETS GIVEN
TO REDUCE OF AIRWAY MUCUS
N-ACETYL-L CYSTEINE
MODE OF ACTION FOR MUCUS CONTROLLING AGENTS
NAC SUBSITUTES ITS OWN SULFHYDRYL GROUP FOR DISULFIDE GROUP
WHICH CAUSES, IN THE MUCUS, THE BOND FORMING THE GEL STRUCTURE, TO BREAK DOWN
SIDE AFFECTS OF MUCUS CONTROLLING AGENTS
AIRWAY OBSTRUCTION
DISAGREEABLE ORDOR DUE TO HYDROGEN SULFIDE
INCREASED CONCENTRATION AND TOXICITY OF NEBULIZER SOLUTION TOWARD END OF TX
NAUSEA
RHINORRHEA
STOMATITIS
REACTIVITY OF ACETYLCYETINE WITH:
RUBBER
COPPER
IRON
CORK
WHICH DISEASE STATE IS DORNASE USED FOR
CF
WHAT IS THE MODE OF ACTION OF DORNASE
PROTOELTYTIC EMZYME BREAK DOWN DNA MATERLIALIZE FROM NEUTROPHILS FOUND IN PURULENT SECRETIONS
SIDE EFFCTS OF DORNASE (MUCUS CONTROLLING AGENT)
VOICE ALTERATION
PHARGYNITIS
RASH
CHEST PAIN
WHAT ARE CONTRAINDICATIONS FOR DORNASE
HYPERSENSITIVITY TO DORNASE
CHINSES HAMSTER OVARY PRODUCTS
COMPONENTS OF OTHER DRUGS CONTAINING DORNASE
ICS - INDICATIONS AND PURPOSE
ORALLY INHALED PREPATION USED FOR ANTI-INFLAMMATOPRY MAINTENANCE THERAPY OF PERSISTENT ASTHMA AND SEVERE COPD
WHAT IS MODE OF ACTION OF ICS
LIPID SOLUBLE DRUGS THAT ACT ON INTRACELLLAR RECEPTORS
FULL ANTI-INFLAMMATORY EFFECTS REQUIRE HOURS TO DAYS
WILL NOT RPOVIDE IMMEDICATE RELEIF OF DYSPNEA FROM AIRWAY OBSTRUCTION
ICS SYSTEMIC SIDE EFFCTS
ADRENAL INSUFF
EXTRAPULMONARY ALLERGY
ACUTE ASTHMA
HPA SUPPRESSION
GROWTH RETARDATION
OSTEOPOROSIS
ICS LOCAL SISDE EFFCTS
OROPHARYNGEAL FUNGAL INFECTIONS
DYSPHONIA
COUGH AND BRONCHOCONSTRICTION
INCORRECT OF MDI
TYPES OF ICS
QVAR, PULMICORT, FLOVENT
COMBINTION WITH ICS
FLUTICASONE PROPIONATE/SALMETEROL (ADVAIR)
BUDESENIDE/FORMETEROL (SYMBICORT)
MOMETASONE/FORMOTEROL (DULERA)
FLUTICASONE FUROATE/VILANTEROL Breztri Aerosphere)
NON STEROIDAL ANTI-ASTHMA DRUGS
MAST CELLS \STABILIZERS
ANTI-LEUKOTRIENES
MONOCLONAL ANTI-BODIES
EXAMPLE OF MAST CELL STABILIZER
Cromolyn sodium
EXAMPLE OF ANTI-LEUKOTRIENES
Montelukast
ZAFIRUKAST
ZILETON
EXAMPLES OF MONCLONAL ANTIBODIES
Omalizumab
MODE OF ACTION FOR CROMOLYN SODIUM
Cromolyn sodium works by preventing the release of histamine and other inflammatory mediators from mast cells, thus stabilizing the cell membrane and reducing allergic reactions.
MODE OF ACTION OFR ZARFIRUKAST AND MONTELUKAST
Zafirlukast and montelukast are leukotriene receptor antagonists that block the action of leukotrienes, reducing bronchoconstriction and inflammation in asthma and allergic reactions.
ADVERSE EFEFCTS OF ANTILEUKOTRIENES
HEADACHE
DYSPEPSIA
LIVER ENZYME ELEVATION
ADVERSE EFFECTS OF OMALIZUMAB
INJECTION SITE
VIRAL INFECTIONS
HEADACHE
SINUSITIS
PHARYNGITIS
NON-STEROIDAL ANTI-ASTHMA DRUGS
ASSESMENT OF DRUG THERAPY
STRATEGIES SIMILAR TO THOSE USED TO ASSESS INITIAL BRONCHODILATOR THERAPY
CLINICAN SHOULD VERIFY THAT PT UNDERSTANDS THAT MEDICATIONS ARE CONTROLLED DRUGS AND NOT RESCUE DRUGS
AEROLOSIZED ANTI-INFECTIVE MEDS (PENTAMIDINE ISETHIATE) WHAT ARE ITS USES
HAS BEEN USED TO TX PNEUMOCYTITS CARNII PNEUMOINIA BUT MAINLY USED TO TX PNUEMONIA JIROVECIand also indicated for patients with HIV/AIDS.
WHY IS PENTAMIDINE ISETHIOATE NOT USED AS MUCH
LIMITED EFFICACY
SIDE EFFECTS OF THE ANTI-INEFECTIVE DRUG PENTAMIDINE ISETHIOATE
COUGH
BRONCHOSPAM
WHEEZE
DYSPNEA
THE ANTI INFECTIVE DRUG RIBRAVIRIN IS USED FOR WHAT
TO TX SEVERE LOWER RESP TRACT INFECTIONS CAUSED BY RSV
HOW IS THE RIBOVIRIN GIVEN
SPAG
WHAT ARE ADVERSE EFFECTS OF THE ANTI-INFECTIVE DRUG RIBOVIRIN
SKIN RASH
EYE LID ERTHYEMA
CONJUCTIVITIS
INHALED TOBRMYCIN (ANIT-INFECTIVE DRUG)
USED TO MAMAGE CHRONIC INFECTIONS WITH P. AERUGINOSA IN PT WITH CF
WHAT ARE THE SIDE EFFCTS OF THE ANTI-INFECTIVE DRUG TOBRAMYCIN
VOICE ALTERATION
TININITIS
AEROSOLIZED ANTI-INFECTIVE -INHALED AZTREONAM (CAYSTON) HOW DOES IT WORK
Aerosolized medication used to treat Pseudomonas aeruginosa infections in patients with cystic fibrosis.
AEROSOLIZED ANTI-INFECTIVE -INHALED AZTREONAM (CAYSTON) SIDE EFFCTS
BRONCHOSPASM
DECREASED FEV1
ALLERGIC REACTIONS
AESOLIZISED ANTI-INFECTIVE AGENTS - COLISITMETHATE SODIUM WHAT IS IT USED FOR
Used to treat pneumonia caused by multidrug-resistant Gram-negative bacteria.
AESOLIZISED ANTI-INFECTIVE AGENTS - COLISITMETHATE SODIUM IDE EFFECTS
Potential nephrotoxicity and neurotoxicity.
AESOLIZISED ANTI-INFECTIVE AGENTS - INHALED ZANAMIVIR
Used to treat influenza virus infections.
INHALED VASODILATOR (INOMAX) USES
TX NEONATES WITH PERSISTENT PULM HYPERTENSION
IMPROIVES V/Q MISMATCH
RELAXES SMOOTH MUSCLES IN PULM VESSELS